The Patent Finder

Controlled Lesion and Immune Response to Pulsed Electric Field Therapy

Galvanize Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,788,463Controlled Lesion and Immune Response to Pulsed Electric Field Therapy
In force
 · Medium confidence
Galvanize Therapeutics, Inc.In forceMedium confidence
Application 18/792,495Controlled Lesion and Immune Response to Pulsed Electric Field Therapy
Pending
Not granted
Galvanize Therapeutics, Inc.PendingNot granted
Application 19/087,408Immune Response to Pulsed Electric Field Therapy
Pending
Not granted
Galvanize Therapeutics, Inc.PendingNot granted
Application 19/684,827Immune Response to Pulsed Electric Field Therapy
Pending
Not granted
Galvanize Therapeutics, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Galvanize Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited